{"id":"W4413316564","doi":"10.1182/bloodadvances.2024015282","title":"Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Takeda Oncology; Genentech; National Institutes of Health; Kyowa Hakko Kirin; Memorial Sloan-Kettering Cancer Center; Chugai Pharmaceutical; Celltrion; Seagen; Kite Pharma; Gilead Sciences; Eisai; BeiGene; Daiichi Sankyo Europe; Sanofi; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"CHOP; Medicine; Prednisone; Internal medicine; Vincristine; Anaplastic large-cell lymphoma; Cyclophosphamide; Lymphoma; Oncology; Peripheral T-cell lymphoma; Chemotherapy; Gastroenterology; Immunology; T cell; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002459639,0.0004463783,0.001027845,0.000148361,0.0001755402,0.000712559,0.0004743218,0.0008399508,0.002449074],"category_scores_gemma":[0.001999619,0.0001947903,0.0008528287,0.0002090778,0.0004532457,0.000606745,0.0003425525,0.001439854,0.0003167898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004728877,"about_ca_system_score_gemma":0.0003936159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002708792,"about_ca_topic_score_gemma":0.0005934267,"domain_scores_codex":[0.9989163,0.0007861363,0.00004419734,0.00009637663,0.00006184207,0.00009525926],"domain_scores_gemma":[0.9986259,0.0005435026,0.0003113456,0.0001142897,0.00005576358,0.0003493416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9714651,0.00173101,0.009577277,0.0001276949,0.000819443,0.00003265592,0.00003234958,0.0006413127,0.002244976,0.00004433601,0.0004060417,0.01287784],"study_design_scores_gemma":[0.4362267,0.3644275,0.180213,0.0001138352,0.003060088,0.0003321948,0.0001141452,0.005689848,0.005985776,0.0009624404,0.002812653,0.00006180672],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978757,0.001030689,0.00009082875,0.0001165429,0.00003948137,0.00009299316,0.0002314029,0.000009236831,0.000513065],"genre_scores_gemma":[0.9984124,0.0002035425,0.00009045918,0.0001042709,0.00007690361,0.000126558,0.0005261644,0.000004002082,0.0004557498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002459639,"threshold_uncertainty_score":0.013008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01115092441455895,"score_gpt":0.3162519335843498,"score_spread":0.3051010091697908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}